NEW YORK (GenomeWeb News) – Cell Biosciences said today that it has acquired sample-prep company Protein Forest in an all-stock transaction worth an undisclosed amount.

In addition, Cell Biosciences said that in connection with the acquisition, it has raised an additional $4 million in equity financing, led by Novo A/S.

The acquisition adds Protein Forest's digital ProteomeChip product, including instrumentation, software, reagents, and consumables, to Santa Clara, Calif.-based Cell Biosciences' portfolio of protein-analysis products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.